MX9700929A - Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina. - Google Patents

Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina.

Info

Publication number
MX9700929A
MX9700929A MX9700929A MX9700929A MX9700929A MX 9700929 A MX9700929 A MX 9700929A MX 9700929 A MX9700929 A MX 9700929A MX 9700929 A MX9700929 A MX 9700929A MX 9700929 A MX9700929 A MX 9700929A
Authority
MX
Mexico
Prior art keywords
prophylaxis
therapy
methods
compositions useful
related conditions
Prior art date
Application number
MX9700929A
Other languages
English (en)
Other versions
MXPA97000929A (es
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Bruce R Gordon
Stuart De Saal
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/487,459 external-priority patent/US5674855A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of MXPA97000929A publication Critical patent/MXPA97000929A/es
Publication of MX9700929A publication Critical patent/MX9700929A/es

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe el tratamiento y la profilaxis de la toxicidad provocada pro endotoxina. Esto es logrado mediante la administracion el sujeto, de composiciones que contienen fosfolipido. Las composiciones están libres de proteína y de péptido, y pueden contener triglicéridos, oros lípidos polares o neutros, ácidos biliares, o sales de ácidos biliares.
MX9700929A 1995-06-07 1995-08-10 Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina. MX9700929A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08288568 1994-08-10
US08487459 1995-06-07
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
PCT/US1995/010189 WO1996004916A1 (en) 1994-08-10 1995-08-10 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions

Publications (2)

Publication Number Publication Date
MXPA97000929A MXPA97000929A (es) 1998-01-01
MX9700929A true MX9700929A (es) 1998-01-31

Family

ID=35560631

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700929A MX9700929A (es) 1995-06-07 1995-08-10 Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina.

Country Status (5)

Country Link
KR (1) KR100372672B1 (es)
BR (1) BR9508584B8 (es)
MX (1) MX9700929A (es)
RU (1) RU2248796C2 (es)
UA (1) UA46739C2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same

Also Published As

Publication number Publication date
KR100372672B1 (ko) 2003-06-19
RU2248796C2 (ru) 2005-03-27
UA46739C2 (uk) 2002-06-17
BR9508584B8 (pt) 2014-11-18

Similar Documents

Publication Publication Date Title
CA2196906A1 (en) Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
BG103335A (en) Application of fumaric acid derivatives
MY110734A (en) Improvements in or relating to dioic acids.
IL70766A (en) Lipopeptides,their manufacture and pharmaceutical compositions containing them
ATE239037T1 (de) Zusammensetzung zur behandlung von nierenversagen
RU94046295A (ru) L-аспартил-d- альфа -аминоалканоил-(s)-n-d-алкилбензиламиды, используемые в качестве искусственных подслащивающих агентов, пищевой состав, способ подслащивания пищевого состава
DE3570362D1 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
DE3472406D1 (en) Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
PT79648A (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
RU97104061A (ru) Фармацевтическая композиция, не содержащая белков и пептидов, способ лечения людей или животных, страдающих от эндотоксемии, и способ профилактики заболевания
ES2124395T3 (es) Utilizacion de esteres de diglicerina contra las impurezas de la piel.
WO1995018608A1 (en) Method of treating disorders of the animal or human body by administering amino acids
SI0994704T1 (en) Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases
ATE86108T1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
MX9304925A (es) Composiciones terapeuticas contra el cancer para profilaxis o para el tratamiento de cancer.
GR82545B (en) Pharmaceutical preparation for treating rheumatics
MX9700929A (es) Metodos y composiciones utiles en la profilaxis y terapia de condiciones relacionadas a la endotoxina.

Legal Events

Date Code Title Description
FG Grant or registration